ARI funds AAF $23,000 for UDAAN Mb12 study India
 

Study of MB12 especially formulated as 25 mg/ml in reducing severity of symptoms of Autism and improving quality of life in Autism

Legal Status: Study approved by the Drugs Controller General of India. 

 Ethical Appoval by I.E.C. of Sir Ganga Ram Hospital, New Delhi: one of Delhi oldest and most reputed tertiary care hospitals.

 udaan.org/autism/proforma.html

 

 

 

 youtu.be/Rd9hwlfHDO0

 

 
        Copyright © Akhil Autism Foundation, All rights reserved, 2009
Website Designed by Compusoft Technologies
        Site best viewed in 1024 X 768 resolution, and Internet Explorer 5 and above